Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003656
What this trial is testing

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Weill Medical College of Cornell University 26
Testing effectiveness (Phase 2)Study completedNCT00026221
What this trial is testing

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 57
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Early research (Phase 1)Ended earlyNCT00701298
What this trial is testing

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Not applicableWithdrawnNCT02454764
What this trial is testing

'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT

Who this might be right for
HBV
Institute of Liver and Biliary Sciences, India
Not applicableStudy completedNCT02922998
What this trial is testing

CD64 and Antibiotics in Human Sepsis

Who this might be right for
Antibiotic Resistant InfectionCritical IllnessSIRS+1 more
University of Ulm 64
Large-scale testing (Phase 3)Study completedNCT04324463
What this trial is testing

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Who this might be right for
CoronavirusSevere Acute Respiratory Syndrome
Population Health Research Institute 6,667
Testing effectiveness (Phase 2)Study completedNCT02218164
What this trial is testing

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of SkinCarcinoma, Squamous Cell
H. Lee Moffitt Cancer Center and Research Institute 8
Post-approval studies (Phase 4)Study completedNCT00534261
What this trial is testing

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 284
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Not applicableLooking for participantsNCT07040774
What this trial is testing

Natural History of Type 1 Interferonopathies: Insights From a European Cohort

Who this might be right for
Genetic DiseaseImmune DysfunctionNeurological Diseases or Conditions+1 more
Imagine Institute 500
Testing effectiveness (Phase 2)Study completedNCT01559090
What this trial is testing

Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 17
Not applicableNot Yet RecruitingNCT06784076
What this trial is testing

Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue

Who this might be right for
Systemic Lupus Erythematosus
NHS Greater Glasgow and Clyde 20
Not applicableStudy completedNCT00999362
What this trial is testing

Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?

Who this might be right for
Kidney Transplantation
University of Aarhus 40
Testing effectiveness (Phase 2)Study completedNCT00395421
What this trial is testing

Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 114
Large-scale testing (Phase 3)Study completedNCT00800735
What this trial is testing

PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 30
Post-approval studies (Phase 4)WithdrawnNCT00771043
What this trial is testing

A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Biogen
Post-approval studies (Phase 4)Study completedNCT02254304
What this trial is testing

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 106
Testing effectiveness (Phase 2)Study completedNCT00524498
What this trial is testing

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Otsuka Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT00623415
What this trial is testing

Flupirtine as Oral Treatment in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Charite University, Berlin, Germany 30
Next Page